Literature DB >> 31141710

Proinflammatory cytokine IFN-γ, lncRNA BANCR and the occurrence of coronary artery disease.

Hongli Wang1, Na Zhang2, Guiru Li3, Bing Xu4.   

Abstract

AIMS: Coronary artery disease (CAD) ranks the leading cause of death globally. Interferon-γ (IFN-γ) gene, along with long noncoding RNA (lncRNA) BRAF-activated noncoding RNA (BANCR), could coordinately function in the occurrence of CAD. We hypothesized that level of IFN-γ, genetic variants of IFN-γ and BANCR gene should be associated with the occurrence of CAD.
MATERIALS AND METHODS: A case-control study was conducted in Chinese population. KEY
FINDINGS: We found that serum level of IFN-γ in CAD cases was significantly higher than that in controls (P < 0.001). Compared with the first quartile, all of the second (OR: 1.87; 95% CIs: 1.33-2.62), the third (OR: 1.79; 95% CIs: 1.30-2.45), and the fourth (OR: 3.98; 95% CIs: 2.59-6.12) quartiles of serum level of IFN-γ were associated with increased risk of CAD (P < 0.05). We found IFN-γ gene (rs2069705 and rs2430561), and 2 variants in lncRNA BANCR (rs6559446 and rs79823312) could increase CAD susceptibility in allelic and dominant model, while IFN-γ rs2069705 and rs2430561, BANCR rs79823312 were also associated with CAD risk in additive model. IFN-γ rs2069705 and rs2430561 were associated with higher level of serum IFN-γ in CAD patients (P < 0.001). SIGNIFICANCE: This study confirmed the crucial role of IFN-γ and lncRNA BANCR in the occurrence of CAD, and might serve as the biomarkers of CAD screening and prevention.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BANCR; Coronary artery disease; Genetic; IFN-γ

Mesh:

Substances:

Year:  2019        PMID: 31141710     DOI: 10.1016/j.lfs.2019.05.066

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

1.  Knockdown of lncRNA H19 alleviates ox-LDL-induced HCAECs inflammation and injury by mediating miR-20a-5p/HDAC4 axis.

Authors:  Yilin Yang; Zhaofei Wang; Ying Xu; Xiaofang Liu; Yehai Sun; Wei Li
Journal:  Inflamm Res       Date:  2022-07-19       Impact factor: 6.986

2.  High BANCR expression is associated with worse prognosis in human malignant carcinomas: an updated systematic review and meta-analysis.

Authors:  Shixu Fang; Zhou Liu; Qiang Guo; Cheng Chen; Xixian Ke; Gang Xu
Journal:  BMC Cancer       Date:  2020-09-09       Impact factor: 4.430

3.  Expression of lncRNA-ANRIL before and after Treatment and Its Predictive Value for Short-Term Survival in Patients with Coronary Heart Disease.

Authors:  Jinhui Sun; Shi Qiu
Journal:  Biomed Res Int       Date:  2021-12-03       Impact factor: 3.411

4.  An Integrative Network Approach to Identify Common Genes for the Therapeutics in Tuberculosis and Its Overlapping Non-Communicable Diseases.

Authors:  Aftab Alam; Hala Abubaker Bagabir; Armiya Sultan; Mohd Faizan Siddiqui; Nikhat Imam; Mustfa F Alkhanani; Ahmad Alsulimani; Shafiul Haque; Romana Ishrat
Journal:  Front Pharmacol       Date:  2022-01-27       Impact factor: 5.810

5.  Risk Prediction of Coronary Artery Stenosis in Patients with Coronary Heart Disease Based on Logistic Regression and Artificial Neural Network.

Authors:  Xiaobing Cheng; Weixing Han; Youfeng Liang; Xianhe Lin; Juanjuan Luo; Wansheng Zhong; Dong Chen
Journal:  Comput Math Methods Med       Date:  2022-03-19       Impact factor: 2.238

6.  Identifying a Serum Exosomal-Associated lncRNA/circRNA-miRNA-mRNA Network in Coronary Heart Disease.

Authors:  Jia Mao; Yufei Zhou; Licheng Lu; Ping Zhang; Runhua Ren; Yaqiong Wang; Jing Wang
Journal:  Cardiol Res Pract       Date:  2021-06-23       Impact factor: 1.866

7.  Reconstruction of a lncRNA-Associated ceRNA Network in Endothelial Cells under Circumferential Stress.

Authors:  Zhuhui Huang; William Adiwignya Winata; Kui Zhang; Yang Zhao; Yang Li; Ning Zhou; Shaoyou Zhou; Wei Fu; Bokang Qiao; Guoqi Li; Yihui Shao; Jubing Zheng; Ran Dong
Journal:  Cardiol Res Pract       Date:  2020-02-14       Impact factor: 1.866

8.  Analysis on the Expression and Prognostic Value of LncRNA FAF in Patients with Coronary Heart Disease.

Authors:  Hai Xu; Xiwen Zhang; Kun Yu; Gang Zhang; Yafei Shi; Yicheng Jiang
Journal:  Biomed Res Int       Date:  2020-11-02       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.